• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】68111

【品名】methyl 3-(bromomethyl)-2-nitrobenzoate

【CA登记号】 

【 分 子 式 】C9H8BrNO4

【 分 子 量 】274.07086

【元素组成】C 39.44% H 2.94% Br 29.15% N 5.11% O 23.35%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(III)

Esterification of 3-methyl-2-nitrobenzoic acid (I) with MeOH in the presence of AcCl at reflux gives methyl 3-methyl-2-nitrobenzoate (II), which is then brominated with NBS in the presence of (PhCO)2O2 in refluxing CCl4 to yield methyl 3-(bromomethyl)-2-nitrobenzoate (III). Oxidation of the bromo derivative (III) with NMMO in acetonitrile leads to methyl 3-formyl-2-nitrobenzoate (IV), which is then condensed with 4-(N-Boc-3-piperidinyl)aniline (V) in refluxing EtOH to afford the corresponding imine (VI). Ring closure of the imine derivative (VI) by means of NaN3 in DMF at 90 °C provides the indazole derivative (VII), which is then treated with NH3 in MeOH at 60 °C to give the carboxamide derivative (VIII). Deprotection of compound (VIII) by means of HCl leads to the hydrochloride salt of the corresponding amine, which is finally resolved by chiral supercritical fluid chromatography (chiral SFC) and treated with HCl .
Aldehyde intermediate (IV) can be prepared in a large-scale synthesis by treatment of methyl 3-methyl-2-nitrobenzoate (II) with DMFA in DMF at 130 °C to give enamine (X), which is finally oxidized with NaIO4 in DMF/H2O .

1 Jones, P., Ontoria Ontoria, J.M., Scarpelli, R., Schultz-Fademrecht, C. (Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA). Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors. EP 2109608, EP 2336120, JP 2010515715, US 2008167345, WO 2008084261.
2 Jones, P., Altamura, S., Boueres, J. et al. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem 2009, 52(22): 7170-85.
3 Wallace, D.J., Baxter, C.A., Brands, K.J.M. et al. Development of a fit-forpurpose large-scale synthesis of an oral PARP inhibitor. Org Process Res Dev 2011, 15(4): 831-40.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 68109 3-methyl-2-nitrobenzoic acid;2-Nitro-m-toluic acid 5437-38-7 C8H7NO4 详情 详情
(II) 68110 methyl 3-methyl-2-nitrobenzoate;2-Nitro-3-methylbenzoic acid methyl ester;3-methyl-2-nitrobenzoic acid methyl ester 5471-82-9 C9H9NO4 详情 详情
(III) 68111 methyl 3-(bromomethyl)-2-nitrobenzoate   C9H8BrNO4 详情 详情
(IV) 68112 methyl 3-formyl-2-nitrobenzoate   C9H7NO5 详情 详情
(V) 68113 tert-butyl 3-(4-aminophenyl)piperidine-1-carboxylate   C16H24N2O2 详情 详情
(VI) 68114 tert-butyl 3-(4-((3-(methoxycarbonyl)-2-nitrobenzylidene)amino)phenyl)piperidine-1-carboxylate   C25H29N3O6 详情 详情
(VII) 68115 methyl 2-(4-(1-(tert-butoxycarbonyl)piperidin-3-yl)phenyl)-2H-indazole-7-carboxylate   C25H29N3O4 详情 详情
(VIII) 68116 tert-butyl 3-(4-(7-carbamoyl-2H-indazol-2-yl)phenyl)piperidine-1-carboxylate   C24H28N4O3 详情 详情
(IX) 68117 2-[4-[3(S)-Piperidinyl]phenyl]-2H-indazole-7-carboxamide 1038915-64-8 C19H20N4O 详情 详情
(X) 68126 (E)-methyl 3-(2-(dimethylamino)vinyl)-2-nitrobenzoate   C12H14N2O4 详情 详情
(X) 68126 (E)-methyl 3-(2-(dimethylamino)vinyl)-2-nitrobenzoate   C12H14N2O4 详情 详情
Extended Information